The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
In vivo effects of a GPR30 antagonist
Open accessAbstract
Estrogen is central to many physiological processes throughout the human body. We have previously shown that the G protein-coupled receptor GPR30/GPER, in addition to classical nuclear estrogen receptors (ERα/β), activates cellular signaling pathways in response to estrogen. In order to distinguish between the actions of classical estrogen receptors and GPR30, we have previously characterized a selective agonist of GPR30, G-1 (1). To complement the pharmacological properties of G-1, we sought to identify an antagonist of GPR30 that displays similar selectivity against the classical estrogen receptors. Here we describe the identification and characterization of a G-1 analog, G15 (2) that binds to GPR30 with high affinity and acts as an antagonist of estrogen signaling through GPR30. In vivo administration of G15 reveals that GPR30 contributes to both uterine and neurological responses initiated by estrogen. The identification of this antagonist will accelerate the evaluation of the roles of GPR30 in human physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Self-citationCryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Self-citationCrystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains
Tanenbaum, D. M., Wang, Y., Williams, S. P., & Sigler, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5998 · Cited by 738
Thomas, P., & Dong, J. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.017 · Cited by 603
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., & Hathaway, H. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100518 · Cited by 590
Self-citationREGULATION OF SIGNAL TRANSDUCTION PATHWAYS BY ESTROGEN AND PROGESTERONE
Edwards, D. P. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120151 · Cited by 502
Brailoiu, E., Dun, S. L., Brailoiu, G. C., Mizuo, K., Sklar, L. A., Oprea, T. I., Prossnitz, E. R., & Dun, N. J. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0017 · Cited by 501
Self-citationAnimal models of depression: An overview
Willner, P. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90076-e · Cited by 428
Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Self-citationRegulatory role of G protein-coupled estrogen receptor for vascular function and obesity
Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190892 · Cited by 373
Self-citationEstrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., & Picard, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.304 · Cited by 327
LESSONS IN ESTROGEN BIOLOGY FROM KNOCKOUT AND TRANSGENIC ANIMALS
Hewitt, S. C., Harrell, J. C., & Korach, K. S. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.115914 · Cited by 292
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E., Ariazi, J., Cordera, F., & Jordan, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776173483 · Cited by 255
Otto, C., Rohde-Schulz, B., Schwarz, G., Fuchs, I., Klewer, M., Brittain, D., Langer, G., Bader, B., Prelle, K., Nubbemeyer, R., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0269 · Cited by 254
Frasor, J., Barnett, D. H., Danes, J. M., Hess, R., Parlow, A. F., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2002-0143 · Cited by 232
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E. A., & Jordan, V. C. (2008) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527623297.ch5 · Cited by 230
The automated tail suspension test: A computerized device which differentiates psychotropic drugs
Steru, L., Chermat, R., Thierry, B., Mico, J.-A., Lenegre, A., Steru, M., Simon, P., & Porsolt, R. D. (1987) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(87)90002-9 · Cited by 213
Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test
Estrada-Camarena, E., Fernández-Guasti, A., & López-Rubalcava, C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300097 · Cited by 211
GPR30 Contributes to Estrogen-Induced Thymic Atrophy
Chunhe, C., Dehghani, B., Magrisso, I. J., Rick, E. A., Bonhomme, E., Cody, D. B., Elenich, L. A., Subramanian, S., Murphy, S. J., Kelly, M. J., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0359 · Cited by 205
Noel, S. D., Keen, K. L., Baumann, D. I., Filardo, E. J., & Terasawa, E. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0299 · Cited by 171
Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders
Ariazi, E., & Jordan, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026610606030203 · Cited by 168
Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Proctor, T., Vandenbark, A. A., & Offner, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803205 · Cited by 156
Visualizing Cellular Phosphoinositide Pools with GFP-Fused Protein-Modules
Balla, T., & Várnai, P. (2002) · Science Signaling · doi:10.1126/stke.2002.125.pl3 · Cited by 150
Pang, Y., Dong, J., & Thomas, P. (2008) · Endocrinology · doi:10.1210/en.2007-1663 · Cited by 138
GPR30: a novel therapeutic target in estrogen-related disease
Prossnitz, E. R., Sklar, L. A., Oprea, T. I., & Arterburn, J. B. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.001 · Cited by 137
Self-citationOwens, J. W., & Ashby, J. (2002) · Critical Reviews in Toxicology · doi:10.1080/20024091064291 · Cited by 126
Gonadal Steroids in the Treatment of Mood Disorders
Epperson, C. N., Wisner, K. L., & Yamamoto, B. K. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00010 · Cited by 120
Lange, C. A., Gioeli, D. G., Hammes, S. R., & Marker, P. C. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160319 · Cited by 119
Wada‐Hiraike, O., Hiraike, H., Okinaga, H., Imamov, O., Barros, R. P. A., Morani, A., Omoto, Y., Warner, M. N., & Gustafsson, J.-Α. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608861103 · Cited by 118
Wang, C., Prossnitz, E. R., & Roy, S. K. (2008) · Endocrinology · doi:10.1210/en.2008-0441 · Cited by 95
Self-citationExpression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia
Dun, S. L., Brailoiu, G. C., Gao, X. Y., Brailoiu, E., Arterburn, J. B., Prossnitz, E. R., Oprea, T. I., & Dun, N. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21980 · Cited by 94
Self-citationGPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat
Kuhn, J., Dina, O. A., Goswami, C., Suckow, V., Levine, J. D., & Hucho, T. B. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06131.x · Cited by 93
Diel, P. R., Geis, R.-B., Caldarelli, A., Schmidt, S., Laudenbach-Leschowsky, U., Voss, A., & Vollmer, G. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.04.006 · Cited by 91
Extra‐nuclear signaling of estrogen receptors
Fu, X., & Simoncini, T. (2008) · IUBMB Life · doi:10.1002/iub.80 · Cited by 81
Menopause and the central nervous system: intervention options
Genazzani, A. R., Spinetti, A., Gallo, R., & Bernardi, F. (1999) · Maturitas · doi:10.1016/s0378-5122(98)00112-1 · Cited by 71
The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell Proliferation
Teng, J., Wang, Z., Prossnitz, E. R., & Bjorling, D. E. (2008) · Endocrinology · doi:10.1210/en.2007-1669 · Cited by 66
Self-citationHigh‐throughput flow cytometry: Validation in microvolume bioassays
Ramírez, S., Aiken, C. T., Andrzejewski, B. P., Sklar, L. A., & Edwards, B. S. (2003) · Cytometry Part A · doi:10.1002/cyto.a.10035 · Cited by 59
Self-citation
Cited by
Advances in the Chemistry of Tetrahydroquinolines
Sridharan, V., Suryavanshi, P. A., & Menéndez, J. C. (2011) · Chemical Reviews · doi:10.1021/cr100307m · Cited by 1,089
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
“In 2009, the GPER-selective antagonist G15 ( Figure 1 ) was identified”
BackgroundSelf-citationGillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Estrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423
Metadata
- Authors
- Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., Dun, N. J., Sklar, L. A., Hathaway, H. J., Arterburn, J. B., Oprea, T. I., & Prossnitz, E. R.
- Venue
- Nature Chemical Biology
- Published
- 2009-05-03
- Volume
- 5
- Issue
- 6
- Pages
- 421-427
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2076908209
- Cited by
- 532
- References
- 42
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.